Prevalence of pulmonary hypertension in patients with chronic kidney disease without dialysis: a meta-analysis
Abstract
Purpose
Recent epidemiological evidence attempts to demonstrate the risk of pulmonary hypertension (PH) among patients with chronic kidney disease (CKD) without dialysis, but prevalence estimates of PH in CKD without dialysis vary widely in the existing studies. This meta-analysis was to summarize the point prevalence of PH in adults with CKD without dialysis.
Methods
PubMed, EMBASE, the Cochrane Collaboration, and the reference lists of relevant articles were searched to identify eligible studies. We used a random-effect meta-analysis model to estimate the prevalence of PH. Associations were tested in subgroups and meta-regression analyses. We also performed sensitivity analyses and assessments of publishing bias.
Results
Twenty-one observational studies (n = 8012 participants) were included in this meta-analysis. The result of analysis in random-effect model showed that the pooled prevalence was 32% (95% CI 23–42%), with significant heterogeneity between these studies (I2 = 98%, P < 0.01). Stratified analyses found that the study design, region, sample size, year of publication, and definition of PH based on PASP ≥ 35 mmHg may explain the variation between studies. Sensitivity analysis further demonstrated the results to be robust. There was no evidence of publication bias.
Conclusions
PH is highly prevalent in patients with CKD without dialysis. Owing to the high heterogeneity, future well-designed and large prospective studies are encouraged to confirm the findings and definitively clarify the potential biological mechanisms.
Keywords
Pulmonary hypertension Prevalence CKD Meta-analysisAbbreviations
- CKD
Chronic kidney disease
- PH
Pulmonary hypertension
- PASP
Pulmonary artery systolic pressure
- RHC
Right heart catheterization
- TRV
Tricuspid regurgitant velocity
Notes
Author contributions
JD and WS conceived and designed the study. WS, YR, and YL screened the abstract and full text, extracted the data, assessed the studies, and drafted the manuscript. WS, YL, WL, and HW performed the statistical analyses. WS, and JD revised the manuscript. All authors read the manuscript and approved the final version.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no competing interests.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Supplementary material
References
- 1.Chadban SJ, Briganti EM, Kerr PG, Dunstan DW, Welborn TA, Zimmet PZ, Atkins RC (2003) Prevalence of kidney damage in Australian adults: the AusDiab kidney study. J Am Soc Nephrol 14(7 Suppl 2):S131–S138CrossRefPubMedGoogle Scholar
- 2.Chen J, Wildman RP, Gu D, Kusek JW, Spruill M, Reynolds K, Liu D, Hamm LL, Whelton PK, He J (2005) Prevalence of decreased kidney function in Chinese adults aged 35 to 74 years. Kidney Int 68(6):2837–2845. https://doi.org/10.1111/j.1523-1755.2005.00757.x CrossRefPubMedGoogle Scholar
- 3.Coresh J, Byrd-Holt D, Astor BC, Briggs JP, Eggers PW, Lacher DA, Hostetter TH (2005) Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 16(1):180–188. https://doi.org/10.1681/asn.2004070539 CrossRefPubMedGoogle Scholar
- 4.Hostetter TH (2004) Chronic kidney disease predicts cardiovascular disease. N Engl J Med 351(13):1344–1346. https://doi.org/10.1056/NEJMe048236 CrossRefPubMedGoogle Scholar
- 5.Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M (2016) 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Revista espanola de cardiologia (English ed) 69(2):177. https://doi.org/10.1016/j.rec.2016.01.002 CrossRefGoogle Scholar
- 6.Archer S, Rich S (2000) Primary pulmonary hypertension: a vascular biology and translational research “Work in progress”. Circulation 102(22):2781–2791CrossRefPubMedGoogle Scholar
- 7.Martin KB, Klinger JR, Rounds SI (2006) Pulmonary arterial hypertension: new insights and new hope. Respirology 11(1):6–17. https://doi.org/10.1111/j.1440-1843.2006.00778.x CrossRefPubMedGoogle Scholar
- 8.Yigla M, Nakhoul F, Sabag A, Tov N, Gorevich B, Abassi Z, Reisner SA (2003) Pulmonary hypertension in patients with end-stage renal disease. Chest 123(5):1577–1582CrossRefPubMedGoogle Scholar
- 9.Havlucu Y, Kursat S, Ekmekci C, Celik P, Serter S, Bayturan O, Dinc G (2007) Pulmonary hypertension in patients with chronic renal failure. Respiration 74(5):503–510CrossRefPubMedGoogle Scholar
- 10.Abdelwhab S, Elshinnawy S (2008) Pulmonary hypertension in chronic renal failure patients. Am J Nephrol 28(6):990–997CrossRefPubMedGoogle Scholar
- 11.Issa N, Krowka MJ, Griffin MD, Hickson LJ, Stegall MD, Cosio FG (2008) Pulmonary hypertension is associated with reduced patient survival after kidney transplantation. Transplantation 86(10):1384–1388CrossRefPubMedGoogle Scholar
- 12.Yigla M, Banderski R, Azzam ZS, Reisner SA, Nakhoul F (2008) Arterio-venous access in end-stage renal disease patients and pulmonary hypertension. Ther Adv Respir Dis 2(2):49–53CrossRefPubMedGoogle Scholar
- 13.Yigla M, Fruchter O, Aharonson D, Yanay N, Reisner SA, Lewin M, Nakhoul F (2009) Pulmonary hypertension is an independent predictor of mortality in hemodialysis patients. Kidney Int 75(9):969–975CrossRefPubMedGoogle Scholar
- 14.Kiykim AA, Horoz M, Ozcan T, Yildiz I, Sari S, Genctoy G (2010) Pulmonary hypertension in hemodialysis patients without arteriovenous fistula: the effect of dialyzer composition. Ren Fail 32(10):1148–1152CrossRefPubMedGoogle Scholar
- 15.Zlotnick DM, Axelrod DA, Chobanian MC, Friedman S, Brown J, Catherwood E, Costa SP (2010) Non-invasive detection of pulmonary hypertension prior to renal transplantation is a predictor of increased risk for early graft dysfunction. Nephrol Dial Transpl 25(9):3090–3096CrossRefGoogle Scholar
- 16.Pabst S, Hammerstingl C, Hundt F, Gerhardt T, Grohe C, Nickenig G, Woitas R, Skowasch D (2012) Pulmonary hypertension in patients with chronic kidney disease on dialysis and without dialysis: Results of the pepper-study. PLoS ONE 7(4):e35310CrossRefPubMedPubMedCentralGoogle Scholar
- 17.Said K, Hassan M, Baligh E, Zayed B, Sorour K (2012) Ventricular function in patients with end-stage renal disease starting dialysis therapy: a tissue Doppler imaging study. Echocardiography 29(9):1054–1059CrossRefPubMedGoogle Scholar
- 18.Emara MM, Habeb MA, Alnahal AA, Elshazly TA, Alatawi FO, Masoud AS (2013) Prevalence of pulmonary hypertension in patients with chronic kidney disease on and without dialysis. Egypt J Chest Dis Tuberc 62(4):761–768CrossRefGoogle Scholar
- 19.Li Z, Liang X, Liu S, Ye Z, Chen Y, Wang W, Li R, Xu L, Feng Z, Shi W (2014) Pulmonary hypertension: Epidemiology in different CKD stages and its association with cardiovascular morbidity. PLoS ONE 9(12):e114392CrossRefPubMedPubMedCentralGoogle Scholar
- 20.Yang QM, Bao XR (2014) Pulmonary hypertension in patients with stage 1-3 chronic kidney disease. Genet Mol Res 13(3):5695–5703CrossRefPubMedGoogle Scholar
- 21.Babua C, Kalyesubula R, Okello E, Kakande B, Sebatta E, Mungoma M, Mondo C (2015) Pattern and presentation of cardiac diseases among patients with chronic kidney disease attending a national referral hospital in Uganda: a cross sectional study. BMC Nephrol 16(1):126CrossRefPubMedPubMedCentralGoogle Scholar
- 22.Suresh H, Arun BS, Moger V, Swamy M (2017) Cardiorenal syndrome type 4: a study of cardiovascular diseases in chronic kidney disease. Indian Heart J 69(1):11–16CrossRefGoogle Scholar
- 23.Selvaraj S, Shah SJ, Ommerborn MJ, Clark CR, Hall ME, Mentz RJ, Qazi S, Robbins JM, Skelton TN, Chen J, Gaziano JM, Djousse L (2017) Pulmonary hypertension is associated with a higher risk of heart failure hospitalization and mortality in patients with chronic kidney disease: the Jackson Heart Study. Circ Heart Fail. https://doi.org/10.1161/circheartfailure.116.003940 PubMedGoogle Scholar
- 24.Reque J, Garcia-Prieto A, Linares T, Vega A, Abad S, Panizo N, Quiroga B, Boira EJC, Lopez-Gomez JM (2017) Pulmonary Hypertension is associated with mortality and cardiovascular events in chronic kidney disease patients. Am J Nephrol 45(2):107–114CrossRefPubMedGoogle Scholar
- 25.O’Leary JM, Assad TR, Xu M, Birdwell KA, Farber-Eger E, Wells QS, Hemnes AR, Brittain EL (2017) Pulmonary hypertension in patients with chronic kidney disease: invasive hemodynamic etiology and outcomes. Pulm Circ 7(3):674–683CrossRefPubMedPubMedCentralGoogle Scholar
- 26.Navaneethan SD, Roy J, Tao K, Brecklin CS, Chen J, Deo R, Flack JM, Ojo AO, Plappert TJ, Raj DS, Saydain G, Sondheimer JH, Sood R, Steigerwalt SP, Townsend RR, Dweik RA, Rahman M (2016) Prevalence, predictors, and outcomes of pulmonary hypertension in CKD. J Am Soc Nephrol 27(3):877–886CrossRefPubMedGoogle Scholar
- 27.Genctoy G, Arikan S, Gedik O (2015) Secondary hyperparathyroidism is associated with pulmonary hypertension in older patients with chronic kidney disease and proteinuria. Int Urol Nephrol 47(2):353–358. https://doi.org/10.1007/s11255-014-0889-5 CrossRefPubMedGoogle Scholar
- 28.Bolignano D, Lennartz S, Leonardis D, D’Arrigo G, Tripepi R, Emrich IE, Mallamaci F, Fliser D, Heine G, Zoccali C (2015) High estimated pulmonary artery systolic pressure predicts adverse cardiovascular outcomes in stage 2–4 chronic kidney disease. Kidney Int 88(1):130–136CrossRefPubMedGoogle Scholar
- 29.Bolignano D, Rastelli S, Agarwal R, Fliser D, Massy Z, Ortiz A, Wiecek A, Martinez-Castelao A, Covic A, Goldsmith D, Suleymanlar G, Lindholm B, Parati G, Sicari R, Gargani L, Mallamaci F, London G, Zoccali C (2013) Pulmonary hypertension in CKD. Am J Kidney Dis 61(4):612–622. https://doi.org/10.1053/j.ajkd.2012.07.029 CrossRefPubMedGoogle Scholar
- 30.Sise ME, Courtwright AM, Channick RN (2013) Pulmonary hypertension in patients with chronic and end-stage kidney disease. Kidney Int 84(4):682–692. https://doi.org/10.1038/ki.2013.186 CrossRefPubMedGoogle Scholar
- 31.Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62(10):1006–1012. https://doi.org/10.1016/j.jclinepi.2009.06.005 CrossRefPubMedGoogle Scholar
- 32.von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP (2014) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg (London, England) 12(12):1495–1499. https://doi.org/10.1016/j.ijsu.2014.07.013 CrossRefGoogle Scholar
- 33.Lv TT, Wang P, Guan SY, Li HM, Li XM, Wang B, Pan HF (2017) Prevalence of pulmonary hypertension in systemic lupus erythematosus: a meta-analysis. Ir J Med Sci. https://doi.org/10.1007/s11845-017-1727-4 Google Scholar
- 34.Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088–1101CrossRefPubMedGoogle Scholar
- 35.Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634CrossRefPubMedPubMedCentralGoogle Scholar
- 36.Yao Z, Wang C, Zhang Q, Ma S, Gui B, Duan C (2017) Prevalence of abdominal artery calcification in dialysis patients with end-stage renal disease: a systematic review and meta-analysis. Int Urol Nephrol 49(11):2061–2069. https://doi.org/10.1007/s11255-017-1685-9 CrossRefPubMedGoogle Scholar
- 37.Park M, Hsu CY, Li Y, Mishra RK, Keane M, Rosas SE, Dries D, Xie D, Chen J, He J, Anderson A, Go AS, Shlipak MG (2012) Associations between kidney function and subclinical cardiac abnormalities in CKD. J Am Soc Nephrol 23(10):1725–1734. https://doi.org/10.1681/asn.2012020145 CrossRefPubMedPubMedCentralGoogle Scholar
- 38.Giaid A (1998) Nitric oxide and endothelin-1 in pulmonary hypertension. Chest 114(3 Suppl):208s–212sCrossRefPubMedGoogle Scholar
- 39.Jarava C, Marti V, Gurpegui ML, Merello JI, Rdez-Quesada B, Palma A (1993) Pulmonary calcification in chronic dialysis patients. Nephrol Dial Transpl 8(7):673–674Google Scholar
- 40.Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, Gomez Sanchez MA, Krishna Kumar R, Landzberg M, Machado RF, Olschewski H, Robbins IM, Souza R (2013) Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 62(25 Suppl):D34–D41. https://doi.org/10.1016/j.jacc.2013.10.029 CrossRefPubMedGoogle Scholar